{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:28:04Z","timestamp":1761658084899,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T00:00:00Z","timestamp":1537401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST106-2314-B-016-026-MY3"],"award-info":[{"award-number":["MOST106-2314-B-016-026-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C105-114","TSGH-C104-118"],"award-info":[{"award-number":["TSGH-C105-114","TSGH-C104-118"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jmii.2018.08.017","type":"journal-article","created":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T19:22:35Z","timestamp":1537644155000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23"],"prefix":"10.1016","volume":"52","author":[{"given":"Kuan-Yu","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hsun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Te-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chun","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Ching","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning-Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2018.08.017_bib1","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/QAD.0b013e32833a3946","article-title":"Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals","volume":"24","author":"van Sighem","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jmii.2018.01.005","article-title":"Clinical features of acute human immunodeficiency virus infection in Taiwan: a multicenter study","volume":"52","author":"Lin","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2018.08.017_bib3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00002030-200208160-00012","article-title":"Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study","volume":"16","author":"Mocroft","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.jmii.2015.10.009","article-title":"Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: a nested case-control study in Kenya","volume":"50","author":"Lupia","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2018.08.017_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmii.2016.04.011","article-title":"Incidence and risk factors of herpes zoster in human immunodeficiency virus-positive patients initiating combination antiretroviral therapy in Taiwan","volume":"51","author":"Lee","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2018.08.017_bib6","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib7","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/501015","article-title":"HIV infection and bone mineral density in middle-aged women","volume":"42","author":"Arnsten","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2018.08.017_bib8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-007-0524-8","article-title":"Risk factors for decreased bone density and effects of HIV on bone in the elderly","volume":"19","author":"Jones","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jmii.2018.08.017_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000\u20132006","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2018.08.017_bib10","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib11","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmii.2018.08.017_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00198-013-2506-3","article-title":"Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients","volume":"25","author":"Casado","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jmii.2018.08.017_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.jmii.2018.08.017_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2003.12.102","article-title":"FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa","volume":"314","author":"Shimada","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jmii.2018.08.017_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2012.07.002","article-title":"Fibroblast growth factor 23: state of the field and future directions","volume":"23","author":"Bhattacharyya","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jmii.2018.08.017_bib16","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/jac\/dkv027","article-title":"Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients","volume":"70","author":"Domingo","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2018.08.017_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155312","article-title":"Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals","volume":"11","author":"Atta","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jmii.2018.08.017_bib18","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1210\/jc.2013-1152","article-title":"Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study","volume":"98","author":"Jovanovich","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jmii.2018.08.017_bib19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00198-008-0780-2","article-title":"Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men","volume":"20","author":"Marsell","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jmii.2018.08.017_bib20","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jbmr.2750","article-title":"Associations of FGF23 with change in bone mineral density and fracture risk in older individuals","volume":"31","author":"Isakova","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jmii.2018.08.017_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/ki.2012.176","article-title":"Update on fibroblast growth factor 23 in chronic kidney disease","volume":"82","author":"Wolf","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.jmii.2018.08.017_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2018.08.017_bib23","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2018.08.017_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jmii.2012.08.026","article-title":"Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors","volume":"47","author":"Tsai","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2018.08.017_bib25","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10067-005-0028-x","article-title":"Abnormalities in the bone mineral metabolism in HIV-infected patients","volume":"25","author":"Garcia Aparicio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jmii.2018.08.017_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib28","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","article-title":"High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study","volume":"24","author":"Bonjoch","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib29","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1097\/QAD.0b013e32833c93fe","article-title":"High prevalence of reduced bone mineral density in primary HIV-1-infected men","volume":"24","author":"Grijsen","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S2213-8587(13)70181-5","article-title":"Skeletal health in adults with HIV infection","volume":"3","author":"Bolland","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jmii.2018.08.017_bib31","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-148-9-200805060-00009","article-title":"Screening for osteoporosis in men: a systematic review for an American College of Physicians guideline","volume":"148","author":"Liu","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jmii.2018.08.017_bib32","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/INF.0000000000001506","article-title":"Low bone mineral density in vertically HIV-infected children and adolescents: risk factors and the role of T-cell activation and senescence","volume":"36","author":"Jimenez","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jmii.2018.08.017_bib33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0043-125073","article-title":"Secondary hyperparathyroidism in HIV-infected patients in central Europe","volume":"50","author":"Noe","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jmii.2018.08.017_bib34","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/QAD.0b013e328349060e","article-title":"Secondary hyperparathyroidism in HIV patients: is there any responsibility of highly active antiretroviral therapy?","volume":"25","author":"Pocaterra","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1574891X09666140609123138","article-title":"Relationship between vitamin D, parathyroid hormone, bone mineral density, fracture and antiretroviral therapy in HIV patients","volume":"9","author":"Das","year":"2014","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"10.1016\/j.jmii.2018.08.017_bib36","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2018.08.017_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11908-010-0144-x","article-title":"The rapidly evolving Research on vitamin D among HIV-infected populations","volume":"13","author":"Overton","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.jmii.2018.08.017_bib38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/QAD.0b013e32831f4685","article-title":"Efavirenz-induced osteomalacia","volume":"23","author":"Herzmann","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.08.017_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/cid\/ciw765","article-title":"Decline in bone mass with tenofovir disoproxil fumarate\/emtricitabine is associated with hormonal changes in the absence of renal impairment when used by HIV-uninfected adolescent boys and young men for HIV preexposure prophylaxis","volume":"64","author":"Havens","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2018.08.017_bib40","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1681\/ASN.2011101006","article-title":"Calcium deficiency reduces circulating levels of FGF23","volume":"23","author":"Rodriguez-Ortiz","year":"2012","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118218302196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118218302196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:23:19Z","timestamp":1761657799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118218302196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1684118218302196"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2018.08.017","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring early developed low bone mineral density in HIV-infected patients by intact parathyroid hormone and circulating fibroblast growth factor 23","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2018.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}